-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Aytu Biopharma, Inc quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2024.
- Aytu Biopharma, Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$930K, a 7.27% decline year-over-year.
- Aytu Biopharma, Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$5.32M, a 67% increase year-over-year.
- Aytu Biopharma, Inc annual Operating Income (Loss) for 2024 was -$5.25M, a 69.2% increase from 2023.
- Aytu Biopharma, Inc annual Operating Income (Loss) for 2023 was -$17.1M, a 84.5% increase from 2022.
- Aytu Biopharma, Inc annual Operating Income (Loss) for 2022 was -$110M, a 86.7% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)